New diabetes drug MK-1403 enters early human safety trials
NCT ID NCT07242469
First seen Nov 21, 2025 · Last updated May 08, 2026 · Updated 19 times
Summary
This early-stage study tests a new medicine called MK-1403 in people with type 2 diabetes. The main goals are to check if it is safe and well-tolerated, and to see how the body processes it. Researchers will also measure if it lowers a marker of inflammation (hsCRP) in the blood. About 52 adults with type 2 diabetes will take part.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS TYPE 2 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Advanced Pharma CR, LLC ( Site 0003)
RECRUITINGMiami, Florida, 33147, United States
Contact Phone: •••-•••-••••
-
Bio-Kinetic Clinical Applications, LLC dba QPS-MO ( Site 0005)
RECRUITINGSpringfield, Missouri, 65802, United States
Contact Phone: •••-•••-••••
-
ProSciento Inc. ( Site 0001)
RECRUITINGChula Vista, California, 91911, United States
Contact Phone: •••-•••-••••
-
QPS-MRA, LLC ( Site 0004)
RECRUITINGMiami, Florida, 33143, United States
Contact Phone: •••-•••-••••
Conditions
Explore the condition pages connected to this study.